Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype.
Masataka TakenakaMartin KoebelDale W GarsedSian FeredayAhwan PandeyDariush EtemadmoghadamJoy HendleyAyako KawabataDaito NoguchiNozomu YanaiharaHiroyuki TakahashiTakako KiyokawaMasahiro IkegamiHirokuni TakanoSeiji IsonishiKazuhiko OchiaiNadia TraficanteSreeja GadipallyTimothy SempleDane VassiliadisKaushalya C AmarasingheJason LiGisela Mir ArnauAikou OkamotoMichael L FriedlanderDavid D L Bowtellnull nullPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
Survival benefit following chemotherapy in OCCC was not associated with pathological misclassification of tumor histotype. HNF1B loss may help identify the subset of patients with OCCC with a more favorable outcome.